我的購物車 (0)
我的帳號資料
我的訂單紀錄
我的學校教授
我的學校課程

[ Tips ] 一分鐘使用導覽

搜尋 
請輸入欲查詢之關鍵字
 
  進階搜尋
依主題瀏覽 
依商品類型瀏覽 
依出版日期瀏覽 
依作者瀏覽(姓) 
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
V
W
Y
Z
銷售排行榜 
 您所選取的商品項目

> Pfizer and the Challenges of the Pharmaceutical Industry (A)

商品編號: W19390
出版日期: 2019/07/31
作者姓名:
Kratochvil, Renate;Nell, Phillip C.
商品類別: Other
商品規格: 17p

再版日期:
地域: United States
產業: Healthcare service industry
個案年度: 2018 -  

 


商品敘述:

In 2018, President of the United States, Donald Trump, criticized the company Pfizer Inc. (Pfizer) for increasing drug prices-which had been a strategic move by Pfizer in response to industry-wide challenges. This announcement highlighted the complex dynamics of the pharmaceutical industry and the big challenges that innovative research and development (R&D)-intensive pharmaceutical companies faced. The entire pharmaceutical industry was being challenged by issues such as decreasing global average returns on investment and increased R&D costs. In addition, the company faced increased competition from companies from other industries and from emerging-market companies. Pfizer''s chief executive officer needed to determine whether or not these changes marked a turning point for the whole industry. Renate Kratochvil is affiliated with BI Norwegian Business School. Phillip C. Nell is affiliated with Wirtschaftsuniversit t Wien.


涵蓋領域:

Industry analysis;Multinational corporations


相關資料:

Case Teaching Note, (W19391), 12p, by Renate Kratochvil, Phillip C. Nell